2792 results
Combining anticoagulants and antiplatelets #Management #PrimaryCare #Cardiology #Antiplatelet #DOAC #Anticoagulation #Combination #BMJ
#PrimaryCare #Cardiology ... #Antiplatelet #DOAC ... #Anticoagulation
Cardiac Valve Replacement - Anticoagulation INR Targets and Antiplatelet by Valve Type

Bioprosthetic valves require at least
Replacement - Anticoagulation ... anticoagulants (DOACs ... 2.4.3; UpToDate Anticoagulation ... #Management #Cardiology ... #INR #Target #DOAC
Anticoagulant Therapy after PCI (patients with AFib)
Dual-Therapy Preferred:
 • Triple therapy = increased bleeding
due to use of DOAC ... derick_gabel via ACCP Cardiology ... Triple #therapy #anticoagulation ... pharmacology #management #cardiology
Atrial Fibrillation (A-Fib) Summary

Symptoms:
• Palpitations, light-headedness, dizziness, dyspnea, exercise intolerance, chest pain, near-syncope, syncope.

Why?
Cardiac:
	• Valvular heart
unknown duration • Anticoagulation ... exclude thrombus • Anticoagulation ... β-blocker or CCB Anticoagulation ... typically needed • DOACs ... diagnosis #management #cardiology
Direct-acting oral anticoagulants (DOACs) for VTE treatment and prevention - Comparison Table

#DOAC #Anticoagulants #Anticoagulation #VTE #Management
anticoagulants (DOACs ... Comparison Table #DOAC ... Anticoagulants #Anticoagulation
Switching Between Anticoagulants and DOACs
VKA, Dabigatran, Rivaroxaban, Apixaban, Edoxaban, Betrixaban, DOAC, Parenteral anticoagulant

DOI: 10.1161/JAHA.120.017559

#Anticoagulants #DOACs #anticoagulation
Anticoagulants and DOACs ... Edoxaban, Betrixaban, DOAC ... Anticoagulants #DOACs ... #anticoagulation
Comparison of oral anticoagulant agents (DOACS + Warfarin)

Reference: ENLS 2017 Pharmacotherapy. Neurocritical Care Journal.

#DOAC #Dosing #Oral
anticoagulant agents (DOACS ... #DOAC #Dosing #Oral ... #Anticoagulation
Anticoagulants Common Reversal Agents
 - Warfarin (Coumadin) → Vitamin K (Phytonadione), 4-factor PCC (Kcentra)
 - Heparin/LMWH
PCC (Kcentra) #anticoagulation ... #doac #noac #pharmacology
Pharmacokinetic Characteristics and Primary Routes of Clearance of Oral Anticoagulant Agents

Warfarin - 100% Hepatic, 0% Renal
Apixaban
Hepatic, 35% Renal #DOAC ... #NOAC #Metabolism ... Clearance #oral #anticoagulation
Reduced DOAC Dosing for Atrial Fibrillation 

#DOAC #Reduced #Dosing #Reduction #Dose #Anticoagulation #Pharmacology #AFib #Renal #CKD
Reduced DOAC Dosing ... Fibrillation #DOAC ... Reduction #Dose #Anticoagulation